Denmark vs Slovak Republic: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Denmark
96.0%
in 2025
Slovak Republic
96.0%
in 2025
Denmark rank
26th
Slovak Republic rank
26th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Denmark
- Slovak Republic
How they compare
Denmark currently reports 96.0% against 96.0% in Slovak Republic, a difference of 0.0%.
The two have swapped places 4 times across 18 shared years of data; in 2008 it was Slovak Republic ahead.
Denmark ranks 26th and Slovak Republic ranks 26th of 192 countries.
Slovak Republic has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Denmark | Slovak Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 43.0% | 49.5% | 6.5% | Slovak Republic |
| 2010s | 93.3% | 97.3% | 4.0% | Slovak Republic |
| 2020s | 96.2% | 96.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Denmark or Slovak Republic?
- Denmark, at 96.0% against 96.0% in Slovak Republic as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Denmark and Slovak Republic?
- 0.0%, with Denmark ahead.
- How many years of comparable data are there for Denmark and Slovak Republic?
- 18 years are reported by both, from 2008 to 2025.
- How do Denmark and Slovak Republic rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Denmark ranks 26th and Slovak Republic ranks 26th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.